The Latest

  • COUR Pharmaceuticals Appoints Dannielle Appelhans as Chief Operating Officer
  • Skip to primary navigation
  • Skip to main content
  • Skip to footer
COUR Pharmaceuticals Logo

COUR Pharmaceuticals

  • Our Company
    • Leadership
    • Advisors
    • Partners
    • Contact
  • Our Technology
    • Pipeline
    • Autoimmune Diseases
    • Allergies
    • Rare Diseases
    • Gene Therapy
  • Our Clinical Trials
  • Publications & Media
    • Press Releases
    • Publications
  • Careers

Leadership

Bringing together extensive expertise in clinical development, scientific research, manufacturing and business, COUR’s leadership team embodies the company’s mission to deliver life-changing therapies designed to reprogram the immune system.

John J. Puisis
John J. Puisis Featured

John J. Puisis

Co - Founder, President & CEO

John J. Puisis LinkedIn Profile
Dannielle Appelhans
Dannielle Appelhans Featured

Dannielle Appelhans

Chief Operating Officer

Dannielle Appelhans LinkedIn Profile
Brian C. Bock
Brian C. Bock Featured

Brian C. Bock

Chief Financial Officer

Brian C. Bock LinkedIn Profile
Roy First, MD
Roy First, MD Featured

Roy First, MD

Chief Medical Officer

Roy First, MD LinkedIn Profile
Adam Elhofy, PHD
Adam Elhofy, PHD Featured

Adam Elhofy, PHD

VP of Immunology & Innovation

Adam Elhofy, PHD LinkedIn Profile
Robert Hodge
Robert Hodge Featured

Robert Hodge

VP of Technical Development

Robert Hodge LinkedIn Profile
Joseph Podojil, PHD
Joseph Podojil, PHD Featured

Joseph Podojil, PHD

Director of Immunology

Joseph Podojil, PHD LinkedIn Profile

Footer

COUR Pharmaceuticals Logo
  • Our Company
  • Our Technology
  • Our Partners
  • Press
  • Careers

©

2023

COUR Pharmaceuticals.
All Rights Reserved.

Privacy Policy • Terms of Use

Back to Top